By Bruce Anneaux, PhD, and James Lindsey III, MS
CAD is the leading cause of death in the United States in both men and women. Treating CAD with bioresorbable vascular scaffolds (BRS) is considered by many to be the “next revolution” in endovascular therapy. This white paper presents the basics of BRS technology, its processing and manufacturing challenges, and its advantages in use with polymer technologies. Download the full paper for more information.